Goldstein E D, Cannistraro R, Atwal P S, Meschia J F
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Department of Clinical Genomics Mayo Clinic, Jacksonville, FL, USA.
Neurohospitalist. 2018 Apr;8(2):82-85. doi: 10.1177/1941874417729983. Epub 2017 Sep 12.
Partial ornithine transcarbamylase deficiency (pOTCD), an enzymatic defect within the urea cycle, is an increasingly recognized etiology for hyperammonemia of unclear source following a stressor within female adults. Here we present a case of newly diagnosed pOTCD following a systemic stressor and prolonged hospitalization course. From a neurological perspective, prompt recognition provided the patient with a swift and near complete recovery. We briefly review the pertinent literature pertaining to this genetically based condition including historical context and current therapeutic approaches. Given the potential morbidity of prolonged hyperammonemia, neurohospitalists need to be aware of partial ornithine transcarbamylase as an entity.
部分鸟氨酸转氨甲酰酶缺乏症(pOTCD)是尿素循环中的一种酶缺陷,是成年女性在应激源后不明来源高氨血症的一种日益被认识到的病因。在此,我们报告一例在全身性应激源和长期住院病程后新诊断的pOTCD病例。从神经学角度来看,及时识别使患者迅速且近乎完全康复。我们简要回顾了与这种基于基因的病症相关的文献,包括历史背景和当前的治疗方法。鉴于长期高氨血症的潜在发病率,神经科住院医师需要了解部分鸟氨酸转氨甲酰酶这种病症。